Home

Clinic Services
Dietary Supplements
Health Concerns
Natural Treatments

Blog & Newsletters
Resources Directory

Online Forms

Email to a Friend

Bookmark this Site

Index to Our Site

CCH Health Review

This free newsletter gives you original and immediately usable information from doctors to help you build your health and vitality!
Email:
Your e-mail address is totally secure. We will never misuse or sell your information.
Clinic Services | Online Store | Health Concerns | Newsletter Archives | Contact Us








Activity/exercise
Case Study- Testimonial
Health Concerns
In the News
Newsletter Archives
Nutrition
Supplements/Vitamins/Botanicals



Oral chelation for environmental lead toxicity


Oral chelation for environmental lead toxicity

Treatment with dimercaptosuccinic acid (DMSA), an oral chelation agent, was linked to reductions in the amount of lead in blood in young children in Zamfara State, Nigeria following environmental lead contamination, according to a study by Jane Greig and colleagues from Médecins Sans Frontières (MSF) published in this week's PLOS Medicine.


The researchers report findings from an MSF program initiated in May 2010 to reduce lead poisoning in children following widespread environmental lead contamination due to gold mining in Zamfara State, Nigeria, leading to the death of an estimated 400 young children in the 3 months before chelation therapy was provided. The analysis included 3180 courses of DSMA chelation therapy administered between 1 June 2010 and 30 June 2011 to 1,156 children ≤5 y of age who had measurements of venous blood lead levels before and after each course of DMSA. The researchers found that, on average, treatment with DSMA was associated with a reduction in venous blood lead levels to 74.5% of the level at the start of the DMSA course. Nine of these 1,156 children died during the period studied, with lead poisoning likely involved in three of these deaths. The researchers report that no clinically severe adverse effects related to DMSA were seen during the study period, and no laboratory findings were recorded that required treatment discontinuation.


While the findings cannot be used to reach any definitive conclusions about the effectiveness or safety of oral DMSA as a treatment for lead poisoning in young children, blood lead levels decreased and the number of deaths was substantially reduced after the program was initiated.

The authors say: "This experience with basic supportive care and chelation in a large paediatric cohort adds significantly to the evidence base for clinical management of epidemic lead poisoning, particularly in resource-poor settings."